Skip Navigation

Faculty Peer Reviewed Publications in 2012

Peer reivewed publications from January to July in 2012.

  1. N. A. Guzzetta, I. A. Russell, and G. D. Williams. Review of the Off-Label Use of Recombinant Activated Factor VII in Pediatric Cardiac Surgery Patients. Anesth.Analg., 2012.
  2. L. L. Hill and A. S. Evers. Perspective: Hospital support for anesthesiology departments: aligning incentives and improving productivity. Acad.Med. 87 (3):348-355, 2012.
  3. H. Kim, F. Szlam, K. A. Tanaka, Locht A. van de, S. Ogawa, and J. H. Levy. The Effects of MDCO-2010, a Serine Protease Inhibitor, on Activated Clotting Time in Blood Obtained from Volunteers and Cardiac Surgical Patients. Anesth.Analg., 2012.
  4. J. H. Levy, F. Szlam, K. A. Tanaka, and R. M. Sniecienski. Fibrinogen and hemostasis: a primary hemostatic target for the management of acquired bleeding. Anesth.Analg. 114 (2):261-274, 2012.
  5. S. Ogawa, F. Szlam, D. Bolliger, T. Nishimura, E. P. Chen, and K. A. Tanaka. The impact of hematocrit on fibrin clot formation assessed by rotational thromboelastometry. Anesth.Analg. 115 (1):16-21, 2012.
  6. W. Shi, R. Jiang, G. P. Dobson, A. Granfeldt, and J. Vinten-Johansen. The nondepolarizing, normokalemic cardioplegia formulation adenosine-lidocaine (adenocaine) exerts anti-neutrophil effects by synergistic actions of its components. J.Thorac.Cardiovasc.Surg. 143 (5):1167-1175, 2012.
  7. G. L. Stahl, S. K. Shernan, P. K. Smith, and J. H. Levy. Complement Activation and Cardiac Surgery: A Novel Target for Improving Outcomes. Anesth.Analg., 2012.
  8. P. K. Smith, L. T. Goodnough, J. H. Levy, R. S. Poston, M. A. Short, G. J. Weerakkody, and L. A. Lenarz. Mortality Benefit With Prasugrel in the TRITON-TIMI 38 Coronary Artery Bypass Grafting Cohort: Risk-Adjusted Retrospective Data Analysis. J.Am.Coll.Cardiol., 2012.
  9. H. Kim, F. Szlam, K. A. Tanaka, Locht A. van de, S. Ogawa, and J. H. Levy. The Effects of MDCO-2010, a Serine Protease Inhibitor, on Activated Clotting Time in Blood Obtained from Volunteers and Cardiac Surgical Patients.Anesth.Analg., 2012.
  10. R. G. Hamilton, J. H. Levy, V. J. Marder, and D. C. Sane. Interference of thrombin in immunological assays for hirudin specific antibodies. J.Immunol.Methods 381 (1-2):50-58, 2012.
  11. A. Zhou, A. Winkler, A. Emamifar, B. Gartland, A. Duncan, A. Antun, M. Arellano, G. A. Tindol, J. H. Levy, W. A. Bornstein, I. R. Horowitz, and H. J. Khoury. Is the Incidence of Heparin-Induced Thrombocytopenia Affected by the Increased Use of Heparin for the Prevention of Deep Venous Thrombosis? Chest, 2012.
  12. J. H. Levy and R. M. Sniecinski. Prohemostatic treatment in cardiac surgery.Semin.Thromb.Hemost. 38 (3):237-243, 2012.
  13. L. A. Yannuzzi, Y. L. Flsher, and J. H. Levy. A classification of abnormal fundus fluorescence. 1971. Retina 32 Suppl 1:711-718, 2012.
  14. L. J. Demma, C. A. Paciullo, and J. H. Levy. Recognition of heparin-induced thrombocytopenia and initiation of argatroban therapy after cardiothoracic surgery in the intensive care unit. J.Thorac.Cardiovasc.Surg. 143 (5):1213-1218, 2012.
  15. R. M. Sniecinski, K. Karkouti, and J. H. Levy. Managing clotting: a North American perspective. Curr.Opin.Anaesthesiol. 25 (1):74-79, 2012.
  16. P. M. Bokesch, G. Szabo, R. Wojdyga, H. P. Grocott, P. K. Smith, C. D. Mazer, S. Vetticaden, A. Wheeler, and J. H. Levy. A phase 2 prospective, randomized, double-blind trial comparing the effects of tranexamic acid with ecallantide on blood loss from high-risk cardiac surgery with cardiopulmonary bypass (CONSERV-2 Trial). J.Thorac.Cardiovasc.Surg. 143 (5):1022-1029, 2012.
  17. J. Gupta, D. D. Denson, E. I. Felner, and M. R. Prausnitz. Rapid local anesthesia in humans using minimally invasive microneedles.  Clin.J.Pain 28 (2):129-135, 2012.
  18. McKernan NP, Culp WC Jr, Knight WL, Johnston WE, Sniecinski RM, Lazar HL. CASE 2--2012 intraoperative diagnosis and management of caseous calcification of the mitral annulus. J Cardiothorac Vasc Anesth. 2012 Apr;26(2):327-32.
  19. Levy JH, Sniecinski RM. Prohemostatic treatment in cardiac surgery. Semin Thromb Hemost. 2012 Apr;38(3):237-43.
  20. Li J, Li JP, Zhang X, Lu Z, Yu SP, Wei L. Expression of heparanase in vascular cells and astrocytes of the mouse brain after focal cerebral ischemia. Brain Res. 1433:137-44, 2012.
  21. Zeng X, Yu SP, Taylor T, Ogle M and Wei L. Protective effect of apelin on cultured rat bone marrow mesenchymal stem cells against apoptosis. Stem Cell Res. 8(3):357-67, 2012.
  22. Choi, K-E.,  Hall, C.C.L., Sun, J-M., Wei, L., Dix, T.A. and Yu, S.P. Pharmacologically Induced Hypothermia Protects against Focal Cerebral Ischemia in Mice. Faseb J, 26(7):2799-810, 2012.
  23. Wei, L., Fraser, J.L., Lu, J-Y., Hu, X., Yu, S.P. Transplantation of hypoxia pre-conditioned bone marrow mesenchymal stem cells enhances angiogenesis and neurogenesis after cerebral ischemia in rats. Neurobiology of Disease, 46(3):635-45, 2012.
  24. Song, M., Mohamad, O., Gu, X, Wei, L. and Yu, S.P. Potential repair of cortical and thalamocortical circuits after transplantation of bonemarrow mesenchymal stem cells into ischemic brain of mice. Cell Transplantation, In press, 2012.
  25. Wei, N., Yu, S.P., Gu, X., Taylor, T.M., Denise, S., Liu, X.F. and Wei, L. Delayed intranasal delivery of hypoxic-preconditioned bone marrow mesenchymal stem cells enhanced cell homing and therapeutic benefits after ischemic stroke in mice. Cell Transplant. In press, 2012.
  26. Nash R, Krishnamoorthy M, Jenkins A, Csete M. Human embryonic stem cell model of ethanol-mediated early developmental toxicity. Exp Neurol. 2012 Mar;234(1):127-35.
  27. O'Toole KK, Jenkins A. The apparent voltage dependence of GABAA receptor activation and modulation is inversely related to channel open probability. Mol Pharmacol. 2012 Feb;81(2):189-97.

Last updated on Tue, 24 Jul 2012